Literature DB >> 12147544

Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure.

Juan Carlos Osorio1, William C Stanley, Axel Linke, Michele Castellari, Quy N Diep, Ashish R Panchal, Thomas H Hintze, Gary D Lopaschuk, Fabio A Recchia.   

Abstract

BACKGROUND: The nuclear receptors peroxisome proliferator-activated receptor-alpha (PPARalpha) and retinoid X receptor alpha (RXRalpha) stimulate the expression of key enzymes of free fatty acid (FFA) oxidation. We tested the hypothesis that the altered metabolic phenotype of the failing heart involves changes in the protein expression of PPARalpha and RXRalpha. METHODS AND
RESULTS: Cardiac substrate uptake and oxidation were measured in 8 conscious, chronically instrumented dogs with decompensated pacing-induced heart failure and in 8 normal dogs by infusing 3 isotopically labeled substrates: 3H-oleate, 14C-glucose, and 13C-lactate. Although myocardial O2 consumption was not different between the 2 groups, the rate of oxidation of FFA was lower (2.8+/-0.6 versus 4.7+/-0.3 micromol x min(-1) x 100g(-1)) and of glucose was higher (4.6+/-1.0 versus 1.8+/-0.5 micromol x min(-1) x 100g(-1)) in failing compared with normal hearts (P<0.05). The rates of lactate uptake and lactate output were not significantly different between the 2 groups. In left ventricular tissue from failing hearts, the activity of 2 key enzymes of FFA oxidation was significantly reduced: carnitine palmitoyl transferase-I (0.54+/-0.04 versus 0.66+/-0.04 micromol x min(-1) x g(-1)) and medium chain acyl-coenzyme A dehydrogenase (MCAD; 1.8+/-0.1 versus 2.9+/-0.3 micromol x min(-1) x g(-1)). Consistently, the protein expression of MCAD and of RXRalpha were significantly reduced by 38% in failing hearts, but the expression of PPARalpha was not different. Moreover, there were significant correlations between the expression of RXRalpha and the expression and activity of MCAD.
CONCLUSIONS: Our results provide the first evidence for a link between the reduced expression of RXRalpha and the switch in metabolic phenotype in severe heart failure.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12147544     DOI: 10.1161/01.cir.0000023531.22727.c1

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  114 in total

Review 1.  Energetics and metabolism in the failing heart: important but poorly understood.

Authors:  Aslan T Turer; Craig R Malloy; Christopher B Newgard; Mihai V Podgoreanu
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-07       Impact factor: 4.294

Review 2.  Mitochondria in heart failure.

Authors:  Mariana G Rosca; Charles L Hoppel
Journal:  Cardiovasc Res       Date:  2010-07-28       Impact factor: 10.787

3.  Integrated Omic Analysis of a Guinea Pig Model of Heart Failure and Sudden Cardiac Death.

Authors:  D Brian Foster; Ting Liu; Kai Kammers; Robert O'Meally; Ni Yang; Kyriakos N Papanicolaou; C Conover Talbot; Robert N Cole; Brian O'Rourke
Journal:  J Proteome Res       Date:  2016-08-03       Impact factor: 4.466

4.  Acute and Chronic Increases of Circulating FSTL1 Normalize Energy Substrate Metabolism in Pacing-Induced Heart Failure.

Authors:  Mitsuru Seki; Jeffery C Powers; Sonomi Maruyama; Maria A Zuriaga; Chia-Ling Wu; Clara Kurishima; Lydia Kim; Jesse Johnson; Anthony Poidomani; Tao Wang; Eric Muñoz; Sudarsan Rajan; Joon Y Park; Kenneth Walsh; Fabio A Recchia
Journal:  Circ Heart Fail       Date:  2018-01       Impact factor: 8.790

Review 5.  Heart failure and loss of metabolic control.

Authors:  Zhao V Wang; Dan L Li; Joseph A Hill
Journal:  J Cardiovasc Pharmacol       Date:  2014-04       Impact factor: 3.105

Review 6.  Mitochondrial energy metabolism in heart failure: a question of balance.

Authors:  Janice M Huss; Daniel P Kelly
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 7.  Energy metabolism in heart failure and remodelling.

Authors:  Joanne S Ingwall
Journal:  Cardiovasc Res       Date:  2008-11-05       Impact factor: 10.787

Review 8.  Cardiac metabolism in heart failure: implications beyond ATP production.

Authors:  Torsten Doenst; Tien Dung Nguyen; E Dale Abel
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

9.  Increasing mitochondrial ATP synthesis with butyrate normalizes ADP and contractile function in metabolic heart disease.

Authors:  Marcello Panagia; Huamei He; Tomas Baka; David R Pimentel; Dominique Croteau; Markus M Bachschmid; James A Balschi; Wilson S Colucci; Ivan Luptak
Journal:  NMR Biomed       Date:  2020-02-17       Impact factor: 4.044

Review 10.  Transcriptional regulation of energy substrate metabolism in normal and hypertrophied heart.

Authors:  Rong Tian
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.